Literature DB >> 15552650

Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation.

S W Redding1, K A Marr, W R Kirkpatrick, B J Coco, T F Patterson.   

Abstract

Candida glabrata has emerged as a common cause of fungal sepsis in bone marrow transplant patients, particularly those receiving fluconazole prophylaxis. Colonization of the lower GI tract and indwelling catheters have been thought to be the primary sources of systemic infection with Candida. We report on a bone marrow transplant patient who developed Candida glabrata sepsis from pre-existing oral colonization.

Entities:  

Mesh：

Year:  2004        PMID： 15552650     DOI： 10.1080/13693780410001731574

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  11 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  Oropharyngeal candidiasis in the era of antiretroviral therapy.

Authors:  George R Thompson; Payal K Patel; William R Kirkpatrick; Steven D Westbrook; Deborah Berg; Josh Erlandsen; Spencer W Redding; Thomas F Patterson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02-13

3.  Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.

Authors:  Anil A Panackal; Jennifer L Gribskov; Janet F Staab; Katherine A Kirby; Michael Rinaldi; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.

Authors:  Steven D Westbrook; William R Kirkpatrick; Nathan P Wiederhold; Cesar O Freytes; Juan J Toro; Thomas F Patterson; Spencer W Redding
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01-09

5.  Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.

Authors:  Paul A Mann; Paul M McNicholas; Andrew S Chau; Reena Patel; Cara Mendrick; Andrew J Ullmann; Oliver A Cornely; Hernando Patino; Todd A Black
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

6.  Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.

Authors:  Haiyan Sun; Yong Chen; Xuan Zou; Huan Li; Xiuyun Yin; Haifeng Qin; Rongrui Liu; Changlin Yu; Qihong Li; Kaitao Yu; Xuelin Han; Jingcai Zou; Cheng Ge; Li Han
Journal:  Clin Oral Investig       Date:  2015-07-30       Impact factor: 3.573

7.  Oral Candida infection and colonization in solid organ transplant recipients.

Authors:  A Dongari-Bagtzoglou; P Dwivedi; E Ioannidou; M Shaqman; D Hull; J Burleson
Journal:  Oral Microbiol Immunol       Date:  2009-06

8.  Screening for drug-resistant Candida yeasts with chromogenic agar.

Authors:  William R Kirkpatrick; Joseph D Zimmerman; Fadi P Haikal; Michael J Broker; Erin Brockway; Annette W Fothergill; Dora I McCarthy; Thomas F Patterson; Spencer W Redding
Journal:  Med Mycol       Date:  2010-09       Impact factor: 4.076

9.  Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.

Authors:  Patricia I Diaz; Bo-Young Hong; Amanda K Dupuy; Linda Choquette; Angela Thompson; Andrew L Salner; Peter K Schauer; Upendra Hegde; Joseph A Burleson; Linda D Strausbaugh; Douglas E Peterson; Anna Dongari-Bagtzoglou
Journal:  J Fungi (Basel)       Date:  2019-06-13

10.  Characterization of the oral fungal microbiome (mycobiome) in healthy individuals.

Authors:  Mahmoud A Ghannoum; Richard J Jurevic; Pranab K Mukherjee; Fan Cui; Masoumeh Sikaroodi; Ammar Naqvi; Patrick M Gillevet
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.